Towards long-acting HIV inhibitors

被引：0
|
作者：
Sarah Crunkhorn
机构：
来源：
Nature Reviews Drug Discovery | 2019年 / 18卷 / 11期
关键词：
D O I：
10.1038/d41573-019-00169-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：826 / 826
相关论文
共 50 条
  • [1] Development of potent and long-acting HIV-1 fusion inhibitors
    Chong, Huihui
    Wu, Xiyuan
    Su, Yang
    He, Yuxian
    AIDS, 2016, 30 (08) : 1187 - 1196
  • [2] Long-acting shot against HIV
    Wolf E.
    Noe S.
    MMW - Fortschritte der Medizin, 2017, 159 (Suppl 2) : 36 - 38
  • [3] Long-acting rilpivirine for HIV prevention
    Jackson, Akil
    McGowan, Ian
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 253 - 257
  • [4] Pharmacokinetics of novel long-acting VEGF inhibitors
    Kumar, Ragava Chetty Nagaraj Naresh
    Xin, Hong
    Li, Pin
    Biswas, Nilima
    Diemer, Tanja
    Ferrara, Napoleone
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [5] Long-acting agents for HIV treatment and prevention
    Linda-Gail Bekker
    Nature Medicine, 2022, 28 : 1542 - 1543
  • [6] In PrEP: Long-acting antivirals for HIV prevention
    Sharma, Amit
    CELL HOST & MICROBE, 2022, 30 (02) : 148 - 150
  • [7] Long-acting PrEP prevents HIV in women
    O'Leary, Karen
    NATURE MEDICINE, 2024, 30 (12) : 3393 - 3393
  • [8] Long-Acting Cabotegravir for HIV/AIDS Prophylaxis
    Engelman, Kathleen D.
    Engelman, Alan N.
    BIOCHEMISTRY, 2021, 60 (22) : 1731 - 1740
  • [9] Long-Acting HIV Drugs for Treatment and Prevention
    Gulick, Roy M.
    Flexner, Charles
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 137 - 150
  • [10] Long-acting antiviral agents for HIV treatment
    Margolis, David A.
    Boffito, Marta
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 246 - 252
12345